BVS - Bioventus Inc.
NEXT EARNINGS:
Mar 10, 2026
(in 13 days)
EPS Est: $0.22
|
Rev Est: $154.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.00
DETAILS
HIGH:
$13.00
LOW:
$13.00
MEDIAN:
$13.00
CONSENSUS:
$13.00
UPSIDE:
49.08%
Market Cap:
584.03M
Volume:
226,853
Avg Volume:
265,930
52 Week Range:
5.81-11.25
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.79
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
930
IPO Date:
2021-02-11
EPS (TTM):
-0.52
P/E Ratio:
-20.46
Revenue (TTM):
573.28M
Total Assets:
727.96M
Total Debt:
335.63M
Cash & Equiv:
41.58M
Rev Growth (5Y):
11.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
3.1%
ROCE:
-2.0%
Debt/Equity:
2.27
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $0.15 | $0.21 | -30.2% | $138.7M | $155.7M | -11.0% |
| 2025-08-06 | $0.21 | $0.22 | -4.5% | $147.7M | $138.8M | +6.4% |
| 2025-05-06 | $0.08 | $0.06 | +33.3% | $123.9M | $145.9M | -15.1% |
| 2025-03-11 | $0.15 | $0.08 | +87.5% | $153.6M | $124.5M | +23.4% |
| 2024-11-05 | $0.06 | $0.06 | 0.0% | $139.0M | $144.8M | -4.0% |
| 2024-08-06 | $0.19 | $0.07 | +171.4% | $151.2M | $137.6M | +9.9% |
| 2024-05-07 | $0.07 | $-0.05 | +240.0% | $129.5M | $118.4M | +9.4% |
| 2024-03-12 | $0.07 | $0.06 | +16.7% | $135.4M | $124.0M | +9.2% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 573.28M | 512.35M | 512.12M | 430.90M | 321.16M | 340.14M | 319.18M | 292.06M | 274.50M | 253.65M | 242.89M | 232.38M |
| Net Income | (33.54M) | (156.23M) | (158.70M) | 19.38M | 16.41M | 6.85M | (12.21M) | (1.64M) | (17.95M) | (34.11M) | (12.90M) | (22.37M) |
| EPS | -0.52 | -2.49 | -2.59 | -0.15 | 0.44 | 0.12 | -0.22 | -0.03 | -0.32 | -0.69 | -0.30 | -0.47 |
| Total Assets | 727.96M | 810.91M | 1.37B | 1.23B | 494.47M | 472.41M | 442.72M | N/A | N/A | 487.35M | 430.42M | N/A |
| Total Debt | 335.63M | 394.85M | 418.07M | 357.68M | 188.38M | 197.97M | 194.83M | N/A | N/A | 196.51M | 170.98M | N/A |
| Cash & Equivalents | 41.58M | 36.96M | 30.19M | 43.93M | 86.84M | 64.52M | 42.77M | N/A | N/A | 4.95M | 15.77M | N/A |
| Operating Cash Flow | 38.80M | 15.34M | (13.54M) | 22.99M | 71.80M | 40.71M | 45.19M | N/A | N/A | 18.92M | 15.11M | 2.75M |
| Free Cash Flow | 37.79M | 7.98M | (15.02M) | 2.10M | 51.13M | 32.37M | 39.13M | N/A | N/A | 11.48M | (5.72M) | (3.61M) |
| FCF per Share | 0.58 | 0.13 | -0.24 | 0.05 | 1.36 | 0.57 | 0.69 | N/A | N/A | 0.21 | -0.10 | -0.06 |
| Book Value | 147.94M | 173.59M | 325.24M | 458.92M | 142.24M | 142.98M | 145.27M | N/A | N/A | 192.34M | 177.49M | N/A |
| Cash & ST Investments | 41.58M | 36.96M | 30.19M | 43.93M | 86.84M | 64.52M | 42.77M | N/A | N/A | 4.95M | 15.77M | N/A |
| ROC Equity | -0.23 | -0.90 | -0.49 | 0.04 | 0.12 | 0.05 | -0.08 | N/A | N/A | -0.18 | -0.07 | N/A |